Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical, Inc. \De\ (LFCR) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to 0.51.

  • Lifecore Biomedical, Inc. \De\'s Debt Ratio rose 2658.5% to 0.51 in Q2 2025 from the same period last year, while for May 2025 it was 0.51, marking a year-over-year increase of 2658.5%. This contributed to the annual value of 0.51 for FY2025, which is 2658.5% up from last year.
  • According to the latest figures from Q2 2025, Lifecore Biomedical, Inc. \De\'s Debt Ratio is 0.51, which was up 2658.5% from 0.49 recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Debt Ratio ranged from a high of 0.51 in Q2 2025 and a low of 0.33 during Q2 2023
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s median Debt Ratio value was 0.38 (recorded in 2021), while the average stood at 0.39.
  • As far as peak fluctuations go, Lifecore Biomedical, Inc. \De\'s Debt Ratio plummeted by 3656.78% in 2021, and later surged by 2658.5% in 2025.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Debt Ratio (Quarter) stood at 0.39 in 2021, then fell by 9.1% to 0.36 in 2022, then increased by 5.35% to 0.38 in 2023, then rose by 15.37% to 0.44 in 2024, then grew by 16.19% to 0.51 in 2025.
  • Its Debt Ratio stands at 0.51 for Q2 2025, versus 0.49 for Q1 2025 and 0.44 for Q4 2024.